The Supreme Court has rejected a request to review a $70 million Risperdal ruling against Johnson & Johnson over male breast growth side effects, meaning the verdict will stand.
A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to…
A Pennsylvania judge upheld a massive Risperdal verdict, but reduced the original punitive damages from $8 billion to $6.8 million.
A new study indicates psychotropic drugs cause genetic changes which leads to weight gain.
A new study warns that only about 1-in-100 serious adverse drug events are reported to the FDA.
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.
A Philadelphia jury has ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who developed breasts as a child due to the side effects of…
A new study warns that giving dementia patients trazodone could be as risky as giving them atypical antipsychotics.
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.
A federal judge cleared the way for a class action lawsuit against Missouri officials, who plaintiffs say allowed unmonitored and uncontrolled prescribing of psychotropic drugs to foster children.